Financial Statements — VET
Balance Sheet
(in billions CAD)| Metric | FY
2025 | FY
2024 | FY
2023 | FY
2022 | FY
2021 | FY
2020 | FY
2019 |
|---|
| Cash & Equivalents | 0.02 | 0.13 | 0.14 | 0.01 | 0.01 | 0.01 | 0.03 |
| Total Current Assets | -- | 0.58 | 0.82 | 0.71 | 0.47 | 0.26 | 0.35 |
| Total Non-current Assets* | -- | 0.14 | 5.41 | 6.28 | 5.43 | 3.85 | 5.52 |
| Total Assets | -- | 6.12 | 6.24 | 6.99 | 5.91 | 4.11 | 5.87 |
| Total Current Liabilities | -- | 0.61 | 0.70 | 0.89 | 0.75 | 0.43 | 0.42 |
| Total Non-current Liabilities* | -- | 0.02 | 2.51 | 2.70 | 3.09 | 2.75 | 3.00 |
| Total Liabilities | -- | 3.30 | 3.20 | 3.59 | 3.84 | 3.18 | 3.41 |
| Retained Earnings | (1.98) | (1.29) | (1.26) | (1.00) | (2.25) | (3.40) | (1.79) |
| Total Stockholder Equity | 2.22 | 2.81 | 3.03 | 3.40 | 2.07 | 0.93 | 2.45 |
* Derived from reported values
Income Statement
(in billions CAD) (except per-share rows)| Metric | FY
2025 | FY
2024 | FY
2023 | FY
2022 | FY
2021 | FY
2020 | FY
2019 |
|---|
| Total Revenue | 1.77 | 1.90 | 2.01 | 3.42 | 2.04 | 1.14 | 1.75 |
| Selling, General & Admin | 0.10 | 0.10 | 0.08 | 0.06 | 0.05 | 0.06 | 0.06 |
| Total Operating Expenses | 0.51 | 0.57 | 0.51 | 0.49 | 0.41 | 0.42 | 0.44 |
| Interest Expense | 0.13 | 0.08 | 0.09 | 0.08 | 0.07 | 0.08 | 0.08 |
| Pretax Income | (0.67) | (0.01) | (0.28) | 2.05 | 1.38 | (1.88) | 0.14 |
| Tax Provision | 0.04 | 0.04 | (0.04) | 0.74 | 0.23 | (0.36) | 0.11 |
| Net Income | (0.65) | (0.05) | (0.24) | 1.31 | 1.15 | (1.52) | 0.03 |
| Basic EPS | (4.25) | (0.30) | (1.45) | 8.03 | 7.13 | (9.61) | 0.21 |
| Diluted EPS | (4.25) | (0.30) | (1.45) | 7.80 | 6.97 | (9.61) | 0.21 |
Cash Flow Statement
(in billions CAD)| Metric | FY
2024 | FY
2023 | FY
2022 | FY
2021 | FY
2020 | FY
2019 |
|---|
| Operating Cash Flow | 0.97 | 1.02 | 1.81 | 0.83 | 0.50 | 0.82 |
| Investing Cash Flow | (0.63) | (0.58) | (1.06) | (0.47) | (0.40) | (0.62) |
| Financing Cash Flow | (0.34) | (0.32) | (0.75) | (0.36) | (0.12) | (0.20) |
